Literature DB >> 27358057

HMGB1/TLR4 signaling induces an inflammatory response following high-pressure renal pelvic perfusion in a porcine model.

Yi Shao1, Minglei Sha1, Lei Chen1, Deng Li1, Jun Lu1, Shujie Xia2.   

Abstract

Percutaneous nephrolithotomy (PCNL) causes a rapid increase in renal pelvic pressure in the kidney, which induces an inflammatory response. High-mobility group box-1 (HMGB1) is known to trigger the recruitment of inflammatory cells and the release of proinflammatory cytokines following ischemia reperfusion injury in the kidney, but the contribution of HMGB1 to the inflammatory response following high-pressure renal pelvic perfusion has not been investigated. In this study, high-pressure renal pelvic perfusion was induced in anesthetized pigs to examine the effect of HMGB1 on the inflammatory response. HMGB1 levels in the kidney increased following high-pressure renal pelvic perfusion, together with elevated levels of inflammatory cytokines in the plasma and kidney and an accumulation of neutrophils and macrophages. Inhibition of HMGB1 alleviated this inflammatory response while perfusion with recombinant HMGB1 had an augmentative effect, confirming the involvement of HMGB1 in the inflammatory response to high-pressure renal pelvic perfusion. HMGB1 regulated the inflammatory response by activating Toll-like receptor 4 (TLR4) signaling. In conclusion, this study has demonstrated that HMGB1/TLR4 signaling contributes to the inflammatory response following high-pressure renal pelvic perfusion in a porcine model and has implications for the management of inflammation after PCNL.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  Toll-like receptor 4; high-mobility group box-1; percutaneous nephrolithotomy

Mesh:

Substances:

Year:  2016        PMID: 27358057     DOI: 10.1152/ajprenal.00480.2015

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  5 in total

1.  Extracellular Vesicles from Albumin-Induced Tubular Epithelial Cells Promote the M1 Macrophage Phenotype by Targeting Klotho.

Authors:  Yijie Jia; Zongji Zheng; Meng Xue; Shuting Zhang; Fang Hu; Yang Li; Yanlin Yang; Meina Zou; Shuangshuang Li; Ling Wang; Meiping Guan; Yaoming Xue
Journal:  Mol Ther       Date:  2019-06-04       Impact factor: 11.454

2.  α-klotho and anemia in patients with chronic kidney disease patients: A new perspective.

Authors:  Yang Xu; Hao Peng; Ben Ke
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

3.  Administration of α-Klotho Does Not Rescue Renal Anemia in Mice.

Authors:  Min Young Park; Carole Le Henaff; Despina Sitara
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

4.  TLR4 contributes to the damage of cartilage and subchondral bone in discectomy-induced TMJOA mice.

Authors:  Xin Liu; Heng-Xing Cai; Pin-Yin Cao; Yaping Feng; Heng-Hua Jiang; Li Liu; Jin Ke; Xing Long
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

5.  High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancer.

Authors:  Tomoya Nakamura; Tatsuo Okui; Kazuaki Hasegawa; Shoji Ryumon; Soichiro Ibaragi; Kisho Ono; Yuki Kunisada; Kyoichi Obata; Masanori Masui; Tsuyoshi Shimo; Akira Sasaki
Journal:  Oncol Rep       Date:  2020-10-02       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.